|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM074101102 |
| 003 |
DE-627 |
| 005 |
20231222021913.0 |
| 007 |
tu |
| 008 |
231222s1980 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0247.xml
|
| 035 |
|
|
|a (DE-627)NLM074101102
|
| 035 |
|
|
|a (NLM)7433476
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Breakey, A S
|e verfasserin
|4 aut
|
| 245 |
1 |
2 |
|a A double-blind, multi-centre controlled trial of 0.25% oxymetazoline ophthalmic solution in patients with allergic and non-infectious conjunctivitis
|
| 264 |
|
1 |
|c 1980
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 16.01.1981
|
| 500 |
|
|
|a Date Revised 21.11.2013
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Oxymetazoline (0.025%) ophthalmic solution, 2 drops 4-times daily, was compared with a placebo in the treatment of allergic and non-infectious conjunctivitis. In this 1 week, double-blind, multi-centre study, oxymetazoline proved significantly superior to the placebo (p < 0.001) in providing rapid and sustained clearing of inflamed conjunctiva. Overall, 84% of allergic patients treated with oxymetzoline were improved compared to 58% on placebo. Patients with non-infectious conjunctivitis exhibited a high degree of improvement (94%) compared to placebo (51%)
|
| 650 |
|
4 |
|a Clinical Trial
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Randomized Controlled Trial
|
| 650 |
|
7 |
|a Imidazoles
|2 NLM
|
| 650 |
|
7 |
|a Placebos
|2 NLM
|
| 650 |
|
7 |
|a Oxymetazoline
|2 NLM
|
| 650 |
|
7 |
|a 8VLN5B44ZY
|2 NLM
|
| 700 |
1 |
|
|a Cinotti, A A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Hirshman, M
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Skowron, R A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Samson, C R
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Danzig, M R
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
|d 1995
|g 2(1980), 6 vom: 08., Seite 353-6
|w (DE-627)NLM023961570
|
| 773 |
1 |
8 |
|g volume:2
|g year:1980
|g number:6
|g day:08
|g pages:353-6
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a GBV_ILN_39
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_121
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 2
|j 1980
|e 6
|b 08
|h 353-6
|